Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies
Elad Mashiach(New York University), Douglas Kondziolka(Neurological Surgery), John G. Golfinos(NYU Langone Health), Zane Schnurman(Neurological Surgery), Sylvia Adams(NYU Langone Health), Erik P. Sulman(NYU Langone Health), Lauren E. Rotman(Neurological Surgery), Kenneth Bernstein(NYU Langone Health), Maryann Kwa(NYU Langone Health), Ruth Oratz(NYU Langone Health), Joshua S. Silverman(NYU Langone Health), Yelena Novik(NYU Langone Health), Jason Gurewitz(New York University), Bernadine R. Donahue(Maimonides Medical Center), Juan Diego Alzate(Neurological Surgery), Marleen Meyers(NYU Langone Health), Fernando De Nigris Vasconcellos(Boston Medical Center)
Cited by 17
Related Papers
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
|Journal of Clinical Oncology|2014|1.3k
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
|JNCI Journal of the National Cancer Institute|2016|521